Importantly, inhibition of CREB activity by the specific inhibitor KG-501 or knocking down CREB reduced proliferation and migration of breast cancer cells and attenuated the difference between the ZsGreen+, the ZsGreen− and the control populations (Fig. 5H–J, Fig, S5E–G). Here, CREB1 is linked to breast cancer.